Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06829420 · ClinicalTrials.gov registry record · NA

Mirror Speech Entrainment: A Novel Technique for Voice Personalized Speech Entrainment for Nonfluent Aphasia

A NA study, sponsored by University of South Florida.

Recruiting
Registry status
NA
Development phase
20
Enrollment target

NCT06829420 is a NA study that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06829420, a NA study, is actively recruiting participants, sponsored by University of South Florida.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The goal of this clinical trial is to test the use of voice personalization through artificial intelligence (AI) voice cloning on speech entrainment tasks to improve language production of persons with aphasia (PWA). The main question the study aims to answer is: \- What is the impact of personalized voice on speech entrainment in PWA compared to traditional speech entrainment? Speech entrainment is a technique used by speech-language pathologists to improve the speech production of PWA. Traditionally, speech therapists act as the model for participants to speak along with to improve their speech production. This study proposes the use of one's own voice (digitally altered) to improve speech production. The study uses a mobile health approach to administer speech entrainment treatment through a mobile app. * Smartphones with the mobile app pre-installed will be mailed to participants at no cost. * Participants will complete treatment in the comfort of their homes. * The experimental treatments involve: mirror speech entrainment (speaking along to one's own voice) and traditional speech entrainment (speaking along to someone else's voice).

Interventions

  • BEHAVIORAL Mirror speech entrainment
  • BEHAVIORAL Traditional speech entrainment: auditory-only
  • BEHAVIORAL Traditional speech entrainment: auditory-visual

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-05-01
Est. Completion 2027-08-01
Phase NA

Sponsor

University of South Florida

252 total trials

What the Registry Record Tells You About NCT06829420

The ClinicalTrials.gov registry entry for NCT06829420 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Mirror speech entrainment is the first listed.

NCT06829420 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06829420 about?

NCT06829420 is a clinical study titled "Mirror Speech Entrainment: A Novel Technique for Voice Personalized Speech Entrainment for Nonfluent Aphasia". The goal of this clinical trial is to test the use of voice personalization through artificial intelligence (AI) voice cloning on speech entrainment tasks to improve language production of persons with aphasia (PWA). The main question the study aims to answer is: \- What is the impact of personaliz...

What is the current status of trial NCT06829420?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-05-01. Estimated completion is 2027-08-01.

What interventions are being tested in trial NCT06829420?

The interventions under investigation include: Mirror speech entrainment (BEHAVIORAL), Traditional speech entrainment: auditory-only (BEHAVIORAL), Traditional speech entrainment: auditory-visual (BEHAVIORAL).

Who is sponsoring clinical trial NCT06829420?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.